Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits

Any patient with a suspected primary adenocarcinoma of the colon, sigmoid or rectum undergoing surgery are eligible. The date of surgery must be known prior to registration. This trial aims to determine if image mapping techniques can improve the concordance between imaging and pathology detection of tumour deposits. Lymph nodes and tumour deposits will be identified on pre-operative scans and mapped by radiologists then shared with pathologists prior to processing the resected specimen. Patients will be managed at their local hospital with standard follow-up. Patients will be followed up for

Trial Details

NCT ID
NCT03303547
Phase
NA
Sponsor
Imperial College London
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • MRI mapping to guide pathological sampling of extranodal tumour deposits
Locations (sample)
  • London, Surrey, United Kingdom|51.50853,-0.12574

Key Eligibility Criteria

  • Suspected primary adenocarcinoma of the colon, sigmoid or rectum (proven by biopsy taken as part of routine clinical practice, patients to be withd…
  • Amenable to surgical resection.
  • Disease spread assessed on imaging
  • Patients having primary surgery and those undergoing neoadjuvant treatment will be included.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →